Neoadjuvant intensity modulated radiotherapy for a single and small (≤5 cm) hepatitis B virus-related hepatocellular carcinoma predicted to have high risks of microvascular invasion: a randomized clinical trial.
Wei X, Jiang Y, Feng S, Lu C, Huo L, Zhou B et al.
Int J Surg 2023; 109: 3052-3060.
Sixty patients were included. The response rate after radiotherapy was 25 per cent. After median follow-up of 68 months. Five-year disease-free survival rates were similar: 56.3 per cent after radiotherapy versus 45.7 per cent after surgery alone, P=0.448.
Comment: this study was too small to make definite conclusions, but the response rate to radiotherapy was pretty low.
24 January 2024
Read paperAcademy
Part of the charitable activity of the Foundation, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
